Researcher Using Big Data To Explore Potential of Kinase Inhibitors To Thwart Brain Cancer

Share
David Plas, PhD, left and doctoral student Nicholas Clark discuss recent big data analyses in glioblastoma multiforme.

David Plas, PhD, left and doctoral student Nicholas Clark discuss recent big data analyses in glioblastoma multiforme.

Contact: Cindy Starr
(513) 558-3505
cindy.starr@uc.edu

Nicholas Clark, a doctoral student at the University of Cincinnati College of Medicine, is taking a big data approach to the problem of glioblastoma multiforme, the most stubborn and aggressive of all brain tumors. Clark, who specializes in biostatistics and bioinformatics, is using a one-year, $25,000 grant to explore whether biomedical big data can predict and optimize responses to a form of targeted therapy for glioblastoma, which claims thousands of American lives each year.

The therapy involves using compounds called kinase inhibitors to target proteins that are frequently activated in human cancers, including glioblastoma.
Clark is a PhD student in the Department of Environmental Health’s new Big Data Biostatistics program. His mentors include Mario Medvedovic, PhD, professor of environmental health, and David Plas, PhD, associate professor of cancer biology and holder of the Anna and Harold W. Huffman Endowed Chair in Glioblastoma Experimental Therapeutics.

“My work with Dr. Plas is in the very beginning stages and is still taking shape,” Clark says. “But in the simplest terms the plan is to help with his research on new potential drug therapies for glioblastoma by making use of the huge amounts of publicly available genomic data on cancer cells.”

Publicly available data include:

•    the toxicity of thousands of drugs to hundreds of cancer cell lines;
•    gene and protein expression of cancer cells in response to treatment with these drugs;
•    and the mutational status of cancer-related genes in these cell lines.

“We hope to use this large-scale data, as well as smaller-scale data and knowledge from experiments in Dr. Plas’s lab, to inform new experiments and develop new insights into glioblastoma treatment,” Clark says.

Clark received his fellowship from the Advanced Multidisciplinary Training Program for Systems Biology, which is run by UC’s Department of Molecular and Cellular Physiology. The multidisciplinary training program is designed to prime researchers to tackle the complex mechanisms of human disease through a cross-disciplinary approach. The training program involves 38 program faculty members paired with students who have matriculated into 13-degree granting PhD programs at UC.

This entry was posted in Press Releases. Bookmark the permalink. Both comments and trackbacks are currently closed.
  • Print This Page
  • Make an Appointment: Schedule Now
  • Sign up for our newsletter!
  • UCNI Weekly Blog
  • Hope Stories

    • Doug’s Story: Stroke Survivor

      Doug's Story: Stroke SurvivorIt was a weekday evening like any other when a friendly customer service representative named Doug became the ultimate customer. His need? Stroke services, A to Z. Doug, a self-described overweight former smoker with high blood pressure and diabetes, was trying...
    • Amanda’s Story: Back Behind the Wheel

      Amanda's Story: Back Behind the WheelAfter two antiepileptic drugs failed to control Amanda's seizures, she underwent testing to see whether she was a candidate for epilepsy surgery. She was, and the results have been something to celebrate.    ...
    • Charlie’s Story: Epilepsy

      Charlie's Story: EpilepsyBy Charlie Shor I have had many adventures in my 57 years, and I have accomplished much. But the main message of my story, which I have been given the opportunity to share, is that anything is possible. If you have...
    • Janis’s Story: Levodopa Pump for Parkinson’s Disease

      Janis's Story: Levodopa Pump for Parkinson's Disease When Janis Yelton gratefully enrolled in a ground-breaking study at the University of Cincinnati Gardner Neuroscience Institute, she was wracked by pain from advanced Parkinson’s disease, taking 32 pills a day, and no longer able to work. Years later, Janis still...
    • Zettie’s Story: Aphasia

      Zettie's Story: Aphasia In November of 2004, Zettie Williams confronted what neurologists consider one of the most feared consequences of stroke. When a therapist showed her a photograph of her son, she knew she was looking at her son, but she couldn’t say...
    • Troy’s Testimonial: ‘Out of 5 Stars, They Get 6’

      Troy’s Testimonial: ‘Out of 5 Stars, They Get 6’ Troy Sheldon has something to say, and he’d like...
    • Troy’s Story: Proton Therapy for Brain Cancer

      Troy's Story: Proton Therapy for Brain Cancer Troy Witt, 65, a London, Kentucky resident and a self-proclaimed "country boy,” says he loves his family, fishing, woodworking and riding on his tractor. But all of these activities have been put on hold since spring 2016 when Witt’s...
    • Dale’s Hope Story: Parkinson’s

      Dale's Hope Story: Parkinson's [hana-flv-player video="/wp-content/videos/Dale_Ankeman_Sunflower_3.flv" width="500" height="377" description="" player="2" autoload="true" autoplay="false" loop="false" autorewind="true" /] After being diagnosed with Parkinson’s disease in 2003, 46-year-old Dale Ankenman was determined not to let it keep him off his bike. Considering his long list of credentials, including former...
    • Frank’s Story: Welcome to ‘the Club’

      Frank's Story: Welcome to 'the Club' Some people have vacation homes. Frank has the UC Gardner Neuroscience Institute. This is where he comes for comprehensive, compassionate medical care for Parkinson’s disease, which he has lived with for 15 years. “They make us feel safe,” says Frank’s...
    • Sunny’s Story: A New MS Family

      Sunny's Story: A New MS Family As Sunny knows, one does not defeat multiple sclerosis. The disease is here today, and it is still here tomorrow. But with help from skilled,...